Literature DB >> 26260398

Association of Chronic Kidney Disease With Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction.

David A Klein1, Daniel H Katz1, Lauren Beussink-Nelson1, Cynthia L Sanchez1, Theresa A Strzelczyk1, Sanjiv J Shah2.   

Abstract

Chronotropic incompetence (CI) is common in heart failure with preserved ejection fraction (HFpEF) and may be a key reason underlying exercise intolerance in these patients. However, the determinants of CI in HFpEF are unknown. We prospectively studied 157 patients with consecutive HFpEF who underwent cardiopulmonary exercise testing and defined CI according to specific thresholds of the percent heart rate reserve (%HRR). CI was diagnosed as present if %HRR <80 if not taking a β blocker and <62 if taking β blockers. Participants who achieved inadequate exercise effort (respiratory exchange ratio ≤1.05) on cardiopulmonary exercise testing were excluded. Multivariable-adjusted logistic regression was used to determine the factors associated with CI. Of the 157 participants, 108 (69%) achieved a respiratory exchange ratio >1.05 and were included in the final analysis. Of these 108 participants, 70% were women, 62% were taking β blockers, and 38% had chronic kidney disease. Most patients with HFpEF met criteria for CI (81 of 108; 75%). Lower estimated glomerular filtration rate (GFR), higher B-type natriuretic peptide, and higher pulmonary artery systolic pressure were each associated with CI. A 1-SD decrease in GFR was independently associated with CI after multivariable adjustment (adjusted odds ratio 2.2, 95% confidence interval 1.1 to 4.4, p = 0.02). The association between reduced GFR and CI persisted when considering a variety of measures of chronotropic response. In conclusion, reduced GFR is the major clinical correlate of CI in patients with HFpEF, and further study of the relation between chronic kidney disease and CI may provide insight into the pathophysiology of CI in HFpEF.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26260398      PMCID: PMC4567946          DOI: 10.1016/j.amjcard.2015.06.038

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  30 in total

1.  Assessment of pacemaker chronotropic response: implementation of the Wilkoff mathematical model.

Authors:  R A Freedman; D L Hopper; J Mah; J Hummel; B L Wilkoff
Journal:  Pacing Clin Electrophysiol       Date:  2001-12       Impact factor: 1.976

2.  Chronic heart failure, chronotropic incompetence, and the effects of beta blockade.

Authors:  K K A Witte; J G F Cleland; A L Clark
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

3.  Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients.

Authors:  Peter H Brubaker; Kee-Chan Joo; Kathryn P Stewart; Brittney Fray; Brian Moore; Dalane W Kitzman
Journal:  J Cardiopulm Rehabil       Date:  2006 Mar-Apr       Impact factor: 2.081

4.  Age-predicted maximal heart rate revisited.

Authors:  H Tanaka; K D Monahan; D R Seals
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

5.  Physical performance as a function of age.

Authors:  P O Astrand
Journal:  JAMA       Date:  1968-09-09       Impact factor: 56.272

6.  Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction.

Authors:  Barry A Borlaug; Vojtech Melenovsky; Stuart D Russell; Kristy Kessler; Karel Pacak; Lewis C Becker; David A Kass
Journal:  Circulation       Date:  2006-11-06       Impact factor: 29.690

7.  Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality: the case of stress echocardiography.

Authors:  J Watanabe; M Thamilarasan; E H Blackstone; J D Thomas; M S Lauer
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

8.  Preclinical diabetic cardiomyopathy: relation of left ventricular diastolic dysfunction to cardiac autonomic neuropathy in men with uncomplicated well-controlled type 2 diabetes.

Authors:  Paul Poirier; Peter Bogaty; François Philippon; Caroline Garneau; Claudette Fortin; Jean-G Dumesnil
Journal:  Metabolism       Date:  2003-08       Impact factor: 8.694

9.  Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction.

Authors:  Guido Grassi; Gino Seravalle; Fosca Quarti-Trevano; Raffaella Dell'Oro; Francesca Arenare; Domenico Spaziani; Giuseppe Mancia
Journal:  Hypertension       Date:  2009-01-05       Impact factor: 10.190

10.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.

Authors:  Walter J Paulus; Carsten Tschöpe; John E Sanderson; Cesare Rusconi; Frank A Flachskampf; Frank E Rademakers; Paolo Marino; Otto A Smiseth; Gilles De Keulenaer; Adelino F Leite-Moreira; Attila Borbély; István Edes; Martin Louis Handoko; Stephane Heymans; Natalia Pezzali; Burkert Pieske; Kenneth Dickstein; Alan G Fraser; Dirk L Brutsaert
Journal:  Eur Heart J       Date:  2007-04-11       Impact factor: 29.983

View more
  13 in total

Review 1.  Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.

Authors:  Sanjiv J Shah; Dalane W Kitzman; Barry A Borlaug; Loek van Heerebeek; Michael R Zile; David A Kass; Walter J Paulus
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

2.  Renal Perfusion during Hemodialysis: Intradialytic Blood Flow Decline and Effects of Dialysate Cooling.

Authors:  Raanan Marants; Elena Qirjazi; Claire J Grant; Ting-Yim Lee; Christopher W McIntyre
Journal:  J Am Soc Nephrol       Date:  2019-05-03       Impact factor: 10.121

Review 3.  How to Develop and Implement a Specialized Heart Failure with Preserved Ejection Fraction Clinical Program.

Authors:  Sanjiv J Shah; Rebecca Cogswell; John J Ryan; Kavita Sharma
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

Review 4.  Cardiorenal syndrome in heart failure with preserved ejection fraction-an under-recognized clinical entity.

Authors:  Akanksha Agrawal; Mario Naranjo; Napatt Kanjanahattakij; Janani Rangaswami; Shuchita Gupta
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

5.  Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction.

Authors:  Eloy Domínguez; Patricia Palau; Eduardo Núñez; José María Ramón; Laura López; Joana Melero; Alejandro Bellver; Enrique Santas; Francisco J Chorro; Julio Núñez
Journal:  ESC Heart Fail       Date:  2018-03-24

6.  Renal Dysfunction in Heart Failure With Preserved Ejection Fraction: Insights From the RELAX Trial.

Authors:  Ravi B Patel; Rupal Mehta; Margaret M Redfield; Barry A Borlaug; Adrian F Hernandez; Sanjiv J Shah; Ruth F Dubin
Journal:  J Card Fail       Date:  2020-01-11       Impact factor: 5.712

7.  An equation to predict peak heart rate for prescribing exercise intensity in middle-aged to older patients requiring hemodialysis.

Authors:  Haruna Oyanagi; Naoto Usui; Atsuhiro Tsubaki; Shuji Ando; Masakazu Saithoh; Sho Kojima; Akihito Inatsu; Hideki Hisadome; Shigeyuki Ota; Akimi Uehata
Journal:  Eur J Appl Physiol       Date:  2022-07-13       Impact factor: 3.346

8.  Chronotropic Competence Indices Extracted from Wearable Sensors for Cardiovascular Diseases Management.

Authors:  Jiankang Wu; Jianan Li; Andrew Seely; Yi Zhu; Sisi Huang; Xiaoqin Wang; Lei Zhao; Hongliang Wang; Herry Christophe
Journal:  Sensors (Basel)       Date:  2017-10-25       Impact factor: 3.576

Review 9.  Targeting Endothelial Function to Treat Heart Failure with Preserved Ejection Fraction: The Promise of Exercise Training.

Authors:  Andreas B Gevaert; Katrien Lemmens; Christiaan J Vrints; Emeline M Van Craenenbroeck
Journal:  Oxid Med Cell Longev       Date:  2017-06-19       Impact factor: 6.543

10.  Beta-blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve-HR trial).

Authors:  Patricia Palau; Julia Seller; Eloy Domínguez; Inés Gómez; José María Ramón; Clara Sastre; Rafael de la Espriella; Enrique Santas; Gema Miñana; Francisco J Chorro; José Ramón González-Juanatey; Julio Núñez
Journal:  Clin Cardiol       Date:  2020-02-19       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.